186 related articles for article (PubMed ID: 16493704)
1. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.
Hwang TL; Liang Y; Chien KY; Yu JS
Proteomics; 2006 Apr; 6(7):2259-72. PubMed ID: 16493704
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody signature in human ductal pancreatic adenocarcinoma.
Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
5. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients.
Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Ozdogan M; Suleymanlar I; Balci MK; Griffith TS; Sanlioglu S
Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952
[TBL] [Abstract][Full Text] [Related]
6. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
[TBL] [Abstract][Full Text] [Related]
10. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
11. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
13. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
[TBL] [Abstract][Full Text] [Related]
15. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
[TBL] [Abstract][Full Text] [Related]
16. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.
Badea L; Herlea V; Dima SO; Dumitrascu T; Popescu I
Hepatogastroenterology; 2008; 55(88):2016-27. PubMed ID: 19260470
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.
Zhou W; Capello M; Fredolini C; Piemonti L; Liotta LA; Novelli F; Petricoin EF
J Proteome Res; 2010 Jun; 9(6):2929-36. PubMed ID: 20433201
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
